Evidence map›Paper›PMID 12457461›Full record

ArticleThe Biochemical journal2003

Early stimulation and late inhibition of peroxisome proliferator-activated receptor gamma (PPAR gamma) gene expression by transforming growth factor beta in human aortic smooth muscle cells: role of early growth-response factor-1 (Egr-1), activator protein 1 (AP1) and Smads.

Mingui Fu, Jifeng Zhang, Yimin Lin, Xiaojun Zhu, Luning Zhao, Mushtaq Ahmad, Markus U Ehrengruber, Yuqing E Chen

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Lysophospholipid-Related Diseases and PPARγ Signaling Pathway.International journal of molecular sciences · 2017
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Nitrated fatty acids reverse pulmonary fibrosis by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2014
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. PPAR gamma, bioactive lipids, and cancer progression.Frontiers in bioscience (Landmark edition) · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Mingui FuCardiovascular Research Institute, Morehouse School of Medicine, 720 Westview Drive SW, Atlanta, GA 30310, USA.
Jifeng Zhang
Yimin Lin
Xiaojun Zhu
Luning Zhao
Mushtaq Ahmad
Markus U Ehrengruber
Yuqing E Chen
Emory University · USUniversity of Zurich · CH

Funding

Vascular Cell Apoptosis: Mediator Role of Transforming Growth Factor-beta-1S06GM008248 · NIGMS · MOREHOUSE SCHOOL OF MEDICINE · PI STILES, JONATHAN K. · 1989 to 2009
$19.8M
The Role of PPAR-gamma in Vascular Lesion FormationR01HL068878 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHEN, YUQING EUGENE · 2002 to 2019
$7.6M
NHLBI NIH HHS HL03676NHLBI NIH HHS HL068878NIGMS NIH HHS S06GM08248
6 · The paper itself

Abstract

Transforming growth factor beta (TGF beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) play major roles in the development of vascular diseases. It has been documented that PPAR gamma activation inhibits the TGF beta signal pathway in vascular smooth muscle cells (VSMC). Here we examined whether TGF beta can regulate PPAR gamma expression. Northern blot analyses revealed that both TGF beta 1 and 2 exert a biphasic effect (early stimulation and late repression) on PPAR gamma gene expression in VSMC. TGF beta rapidly and transiently induced early growth-response factor-1 (Egr-1) expression through the mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1 (MEK1)/ERK-mediated pathway. Inhibition of MEK1/ERK by PD98059 not only abrogated the induction of Egr-1 but also abolished the rapid and transient induction of PPAR gamma by TGF beta. Furthermore, overexpression of NAB2, a repressor of Egr-1 activation, also blocked the induction of PPAR gamma by TGF beta in VSMC, suggesting that Egr-1 mediates the rapid and transient induction of PPAR gamma by TGF beta. With regard to the TGF beta repression of PPAR gamma expression, activator protein 1 (AP1) and Smad3/4 dramatically inhibited the PPAR gamma promoter activity in transient-transfection studies. In contrast, adenovirus-mediated overexpression of a dominant-negative form of c-Jun partially rescued the TGF beta-induced PPAR gamma repression in VSMC. Taken together, our data demonstrate that Egr-1, AP1 and Smad are part components of the TGF beta signal transduction pathway that regulates PPAR gamma expression.

Indexed as

Gene Expression RegulationImmediate-Early ProteinsAortaBone Morphogenetic Protein 2Bone Morphogenetic ProteinsCells, CulturedDNA-Binding ProteinsEarly Growth Response Protein 1Fibroblast Growth Factor 2Genes, ReporterHumansInterleukin-1Mitogen-Activated Protein KinasesMuscle, Smooth, VascularPlatelet-Derived Growth FactorPromoter Regions, GeneticBMP2 protein, humanBone Morphogenetic Protein 2Bone Morphogenetic ProteinsDNA-Binding ProteinsEarly Growth Response Protein 1EGR1 protein, humanFibroblast Growth Factor 2Immediate-Early ProteinsInterleukin-1Mitogen-Activated Protein KinasesPlatelet-Derived Growth FactorReceptors, Cytoplasmic and NuclearSmad ProteinsTetradecanoylphorbol AcetateTrans-ActivatorsTranscription Factor AP-1Transcription FactorsTransforming Growth Factor beta

Identifiers

PMID12457461
PMCPMC1223218
OpenAlexW2084634578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.